This new protocol was published. The objective is to assess the effects of glucagon‐like peptide‐1 analogues on overweight or obese adults.Read the full details at The Cochrane Library here.

A 2022 update of this very important review was published.The authors' conclusions are:

In our new prototype Cochrane Review, published on 3 November 2023 we found that insulin can be kept at room temperature for months without losing potency, offering hope to people living with diabetes in regions with limited access to healthcare or stable powered refrigeration. This is also especially relevant for people who are exposed to prolongued heat waves due to the climate crisis.

Cochrane führt seit April 2020 ein Register, in dem sämtliche klinische Studien zu COVID-19 laufend erfasst werden. Aktuell sind es 90.000 Datensätze. Aktualisierungen werden durch maschinelles Lernen und Cochrane Crowd unterstützt.

Help us find trials!Join Cochrane Crowd (https://crowd.cochrane.org) today and help Cochrane to identify reports of randomised trials. No experience necessary. It’s great way to get involved with Cochrane work.You can also work on records that are of interest to you. Just complete the very brief, interactive training, and then you can add keywords of interest (e.g. diabetes, obesity, thyroid gland) in your Settings.

Our review "Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia" (authors: Bernd Richter, Bianca Hemmingsen, Maria-Inti Metzendorf, Yemisi Takwoingi) belongs to the top 10% most downloaded Cochrane Reviews of the years 2018/19.